Enliven (ELVN) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- −$0.49
- EPS estimate
- −$0.54
- EPS surprise
- +8.72%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 13, 2025
Enliven's latest quarter in the table is Q2 2025, reported on August 13, 2025. Enliven posted a loss of $0.49 per share, narrower than the $0.54 loss analysts expected, an 8.72% beat. No revenue was reported and no revenue estimate was given. A year earlier, in Q2 2024, the loss was $0.41 per share, so the loss widened by about 20%.
Every quarter in the table is a loss, with no reported revenue. The record has a gap: Q3 and Q4 2022 are missing. Losses before the gap were on a much larger per-share scale, from $1.74 to $17.24 per quarter, so the two periods do not compare directly. Since 2023 the quarterly loss has stayed between $0.41 and $0.80 per share. Full-year losses were $2.19 per share in 2023 and $1.89 in 2024. The first half of 2025 adds up to a loss of $1.06, against $0.95 a year earlier. Over the 20 quarters shown, the loss came in better than the estimate 13 times.
The table has no results after Q2 2025. In past years Enliven reported its third quarter in early to mid-November. Later reports will show whether the quarterly loss stays near $0.50 per share.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2025 | Aug 13, 2025 | −$0.54 | −$0.49 | +8.72% | $0.00 | SEC |
| Q1 2025 | May 14, 2025 | −$0.50 | −$0.57 | −13.66% | $0.00 | SEC |
| Q4 2024 | Mar 13, 2025 | −$0.51 | −$0.46 | +10.61% | $0.00 | SEC |
| Q3 2024 | Nov 13, 2024 | −$0.50 | −$0.48 | +3.40% | $0.00 | SEC |
| Q2 2024 | Aug 13, 2024 | −$0.55 | −$0.41 | +25.45% | $0.00 | SEC |
| Q1 2024 | May 14, 2024 | −$0.54 | −$0.54 | +0.61% | $0.00 | SEC |
| Q4 2023 | Mar 14, 2024 | −$0.54 | −$0.47 | +12.43% | $0.00 | SEC |
| Q3 2023 | Nov 9, 2023 | −$0.47 | −$0.51 | −7.94% | $0.00 | SEC |
| Q2 2023 | Aug 10, 2023 | −$0.40 | −$0.41 | −3.35% | $0.00 | SEC |
| Q1 2023 | May 11, 2023 | −$0.63 | −$0.80 | −26.32% | $0.00 | SEC |
| Q2 2022 | Aug 3, 2022 | −$1.71 | −$1.74 | −1.71% | $0.00 | — |
| Q1 2022 | May 6, 2022 | −$2.31 | −$2.23 | +3.41% | $0.00 | — |
| Q4 2021 | Mar 15, 2022 | −$3.00 | −$2.00 | +33.43% | $0.00 | SEC |
| Q3 2021 | Nov 9, 2021 | −$3.38 | −$2.20 | +34.97% | $0.00 | SEC |
| Q2 2021 | Aug 6, 2021 | −$3.64 | −$2.96 | +18.76% | $0.00 | SEC |
| Q1 2021 | May 11, 2021 | −$3.34 | −$2.32 | +30.54% | $0.00 | SEC |
| Q4 2020 | Mar 5, 2021 | −$3.35 | −$2.62 | +21.85% | $0.00 | SEC |
| Q3 2020 | Nov 5, 2020 | −$3.21 | −$2.88 | +10.15% | $0.00 | SEC |
| Q2 2020 | Aug 14, 2020 | −$2.25 | −$2.36 | −4.95% | $0.00 | SEC |
| Q1 2020 | May 7, 2020 | −$3.41 | −$17.24 | −405.91% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did Enliven (ELVN) last report earnings?
Enliven last reported on Aug 13, 2025, covering fiscal Q2 2025.
Did ELVN beat earnings estimates?
Yes. Enliven reported EPS of −$0.49 for Q2 2025 against a −$0.54 estimate — a 8.72% beat.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.